Am I a Good Candidate for a Liver Transplant? A Hepatologist Explains Who Needs One — and Who Doesn't

Introduction

Patients ask me two opposite questions in the same week:

"Doctor, am I sick enough to need a transplant?" "Doctor, am I too sick for one?"

Both are the right question. A liver transplant isn't a last resort and it isn't a default treatment for every damaged liver — it's a timing decision, and getting the timing wrong in either direction costs patients years.

One thing I want to correct upfront, because it shapes almost everything below: most of what patients read about transplant eligibility online is written for the American deceased-donor system. In India, roughly 8 in 10 liver transplants are living donor (LDLT) — a family member gives part of their liver. That changes the eligibility conversation substantially: it's not "how sick do you have to be to move up a waiting list," it's "is transplant the right call, and do you have a donor." I'll flag where that distinction matters.

The one-line answer

A transplant is worth the risk when living with the diseased liver has become more dangerous than the surgery itself. Everything in an evaluation is an attempt to answer that question honestly — not to sell you on surgery.

Does everyone with cirrhosis need a transplant? No.

Cirrhosis has two clinically distinct phases, and only one of them puts transplant on the table.

Compensated cirrhosis — the liver is scarred but still functioning. Patients are often working, asymptomatic, with no fluid buildup or confusion. This group needs monitoring, not transplant evaluation.

Decompensated cirrhosis — the liver has stopped keeping up. This is the group I actually start evaluating:

• Recurrent ascites (fluid buildup)
• Spontaneous bacterial peritonitis
• Jaundice
• Hepatic encephalopathy (confusion)
• Variceal bleeding
• Worsening kidney function
• Sarcopenia (muscle wasting)
• Repeated hospital admissions for any of the above

Case: early referral changed the outcome. A 55-year-old male presented with acute-on-chronic liver failure, deteriorating rapidly — the kind of presentation where the decision window can be as tight as 2 to 3 days. His wife came forward as donor; she wasn't a blood-group match, so the transplant proceeded as ABO-incompatible, within the selected-cohort protocol where survival outcomes run 80-85% in appropriately selected, desensitized cases. Early recognition and early transplant, not last-minute rescue, was what made survival possible.

What actually causes the liver disease that leads here

• MASLD (formerly NAFLD/fatty liver) — the fastest-growing indication in India right now
• Alcohol-related liver disease
• Chronic hepatitis B and C
• Autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis
• Wilson disease, hemochromatosis, alpha-1 antitrypsin deficiency
• Acute liver failure (days-long deterioration in a previously healthy liver — this one moves fast)
• Selected hepatocellular carcinoma (HCC)

How I actually decide — beyond the lab numbers

This is the part that separates a real evaluation from a checklist.

Disease severity numbers matter — bilirubin, INR, creatinine, sodium, albumin, platelets, imaging. But how MELD is actually used changes entirely depending on whether we're considering DDLT or LDLT, and this is where most patient-facing content gets it backwards. In DDLT, MELD dictates allocation — it's "sickest first," and a high score is what pushes a patient up a deceased-donor waitlist. In LDLT, a living donor is directed specifically to the patient, so MELD isn't competing for a spot — it becomes a measure of surgical risk instead. Paradoxically, a lower or moderate MELD is often ideal for LDLT: the patient is stronger, tolerates surgery better, and recovers more smoothly while the partial graft regenerates. Wait too long for MELD to climb, and the patient may become too sick to safely survive an LDLT — the opposite of how the DDLT logic works. This is exactly why early evaluation, long before a patient is critically ill, matters more in the LDLT-majority reality of Indian transplant medicine than it does in a pure allocation-queue system.

On cancer eligibility specifically: I don't work off a rigid checklist like Milan criteria alone. Tumor size and number are a starting point, not the whole picture — vascular invasion, response to bridging therapy, and overall liver reserve all factor into whether transplant is the right call for a given patient. [INSERT: a sentence or two on how this case-by-case judgment actually plays out — e.g., a borderline case Dr. Kalal took to transplant that a strict-criteria approach would have excluded, or vice versa.]

Physical fitness for major surgery — heart, lung, kidney function, nutritional status, frailty, infection status.

Psychological and family readiness — lifelong medication adherence isn't optional after transplant, and I look for whether a patient and their support system understand that before, not after, listing.

Case: delayed referral, severe alcoholic hepatitis. One of the most heartbreaking patterns I see: patients with severe alcoholic hepatitis reaching a tertiary center only after multi-organ failure has already set in. By the time they arrive in the ICU, the critical window for intervention has closed — infection often rules out standard therapy, and an unstable patient can't safely undergo transplant evaluation. This pattern disproportionately hits patients in their 30s and 40s with young families, and telling that family we're out of options because the patient arrived too late is one of the hardest conversations in this specialty. Severe alcoholic hepatitis is a medical emergency, not a wait-and-watch diagnosis — early referral to a specialized liver unit is the decisive factor between a second chance and a preventable outcome.

When you do NOT need a transplant

• Compensated, stable cirrhosis
• Reversible liver injury
• Early fibrosis
• Successfully treated hepatitis
• MASLD without decompensation

Case: recovered without transplant. A young male came in with a first episode of severe alcoholic hepatitis — Maddrey discriminant function above 80, a picture that looked transplant-bound. A sepsis screen was negative. With steroid therapy and aggressive nutritional support, he recovered fully without transplantation. Evaluation isn't a pipeline toward surgery — sometimes the right call is intensive medical management, and a first-episode presentation with good support behind it is exactly where that call gets made.

When transplant isn't possible yet (not never)

• Active uncontrolled infection
• Ongoing alcohol or substance use
• Severe uncontrolled cardiac disease
• Malignancy outside transplant criteria
• Not currently fit for major surgery

Most of these are reversible with treatment first — this is a "not now," not a permanent door closing, and I make a point of telling patients that distinction explicitly.

Living donor vs. deceased donor — the part most articles underweight

In India, this is usually the real fork in the road, not MELD-based queue position.

LDLT (living donor):

• Shorter wait, planned timing
• Avoids deterioration while waiting
• Requires a compatible, willing, medically fit donor — usually family
• Donor evaluation is its own rigorous process (blood group compatibility, graft-to-recipient weight ratio, psychological and social assessment to rule out coercion)

DDLT (deceased donor):

• No risk to a living donor
• Dependent on organ availability through state allocation (ZTCC in Maharashtra) — realistically longer and less predictable than in countries with larger deceased-donor pools

Family counseling for LDLT is one of the most delicate parts of this practice — we're no longer just treating a patient, we're asking a perfectly healthy person to undergo major surgery. My responsibility in these sessions is absolute transparency: confirming the donor is stepping forward voluntarily, free of unspoken family pressure or guilt, and laying out the unvarnished risks, the dual recovery timeline, and the emotional, physical, and financial toll on the whole household. A successful LDLT needs a unified, realistic, committed family — not just surgical precision. Nobody leaves that conversation without understanding that the donor's wellbeing is the one non-negotiable in the room.

Myths I correct weekly

"I'm too old." Physiological fitness matters more than age on paper.

"My last blood test looked fine, so I'm off the hook." Isolated lab values matter less than complications and trajectory.

"Cancer rules out transplant." Not automatically — see above.

"Transplant is my last resort." It's a planned treatment when timed right, not a rescue attempted too late.

FAQ

Can my liver recover without a transplant? Depending on cause and severity, yes — this is exactly what evaluation is for.

How long does evaluation take? Varies with case complexity and how quickly investigations are completed. [Verify typical timeline at Gleneagles before publishing — don't want to state a number we can't stand behind.]

Can I return to work after transplant? Most patients do, once recovery and immunosuppression are stabilized.

Will I need medication for life? Yes — lifelong immunosuppression is non-negotiable to prevent rejection.

Final thought

Don't wait until you're critically ill to ask whether you're a candidate. Evaluation doesn't commit you to surgery — it tells you where you actually stand, and in decompensating liver disease, time is the one resource you can't get back once it's gone.

Treating the patient, not just the numbers, is what makes a transplant truly successful. In liver disease, time is our most precious resource — let's not lose it waiting.

— Dr. Chetan Kalal, Hepatologist & Liver Transplant Specialist